Cart

“Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence PDF” has been added to your cart. View cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item	Thumbnail image	Product	Price	Quantity	Subtotal
×		Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial PDF	$40.00	Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial PDF quantity	$40.00
×		Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial PDF	$40.00	Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial PDF quantity	$40.00
×		Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults PDF	$40.00	Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults PDF quantity	$40.00
×		Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study PDF	$40.00	Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study PDF quantity	$40.00
×		Impact of Comorbid Attention Deficit Disorder on the Direct Medical Costs of Treating Adults With Depression in Managed Care PDF	$40.00	Impact of Comorbid Attention Deficit Disorder on the Direct Medical Costs of Treating Adults With Depression in Managed Care PDF quantity	$40.00
×		Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance PDF	$40.00	Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance PDF quantity	$40.00
×		Divalproex in the Treatment of Acute Bipolar Depression: A Preliminary Double-Blind, Randomized, Placebo-Controlled Pilot Study PDF	$40.00	Divalproex in the Treatment of Acute Bipolar Depression: A Preliminary Double-Blind, Randomized, Placebo-Controlled Pilot Study PDF quantity	$40.00
×		Independent Effects of Apolipoprotein E and Cerebrovascular Burden on Later-Life Depression: The Wisconsin Longitudinal Study PDF	$40.00	Independent Effects of Apolipoprotein E and Cerebrovascular Burden on Later-Life Depression: The Wisconsin Longitudinal Study PDF quantity	$40.00
×		Relationships Between Self-Injurious Behaviors, Pain Reactivity, and Î²-Endorphin in Children and Adolescents With Autism PDF	$40.00	Relationships Between Self-Injurious Behaviors, Pain Reactivity, and Î²-Endorphin in Children and Adolescents With Autism PDF quantity	$40.00
×		How Can We Use Depression Severity to Guide Treatment Selection When Measures of Depression Categorize Patients Differently? PDF	$40.00	How Can We Use Depression Severity to Guide Treatment Selection When Measures of Depression Categorize Patients Differently? PDF quantity	$40.00
×		Intoxications Associated With Agitation, Tachycardia, Hypertension, and Fever: Differential Diagnosis, Evaluation, and Management PDF	$40.00	Intoxications Associated With Agitation, Tachycardia, Hypertension, and Fever: Differential Diagnosis, Evaluation, and Management PDF quantity	$40.00
×		Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence PDF	$40.00	Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence PDF quantity	$40.00
Coupon:

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.

Cart totals

Subtotal	$480.00
Total	$480.00

Proceed to checkout